Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Executives On The Move

Set Alert for Executives on The Move

Executives On The Move: UCB, LAVA Therapeutics and More

Recent executive moves in the industry include C-suite changes at Arcus Biosciences and UCB. Meanwhile, new directors were appointed at Arovella Therapeutics and LAVA Therapeutics.

Executive Changes Leadership

Executives On The Move: Changes At Albireo Pharma, AbbVie And Lundbeck

Recent executive moves in the industry include C-suite changes at Albireo Pharma, Aptevo Therapeutics and AbbVie. Meanwhile, new directors were appointed at Amarin and Oculis Holding.

Executive Changes Leadership

Executives On The Move: Avidity Biosciences, Exicure and More

Recent executive moves in the industry include C-suite changes at Avidity Biosciences and BioAtla. Meanwhile, new directors were appointed at Exicure and Alimera Sciences.

Executive Changes Leadership

Viatris To Bring In Plenty Of Brand Knowledge With New CEO Smith

Only three months after joining Viatris’ board of directors, Scott Smith, famed for spearheading Celgene’s successful and lucrative Inflammation and Immunology division, has been announced as the company’s new CEO, beginning 1 April.

Executive Changes Companies

Executives On The Move: Sandoz, Clyra Medical Technologies, IRLAB Therapeutics and More

Recent executive moves in the industry include C-suite changes IRLAB Therapeutics and Mercy Bioanalytics. Meanwhile, new directors were appointed at Clyra Medical Technologies and Jasper Therapeutics, while Sandoz has a new chairman-designate.

Executive Changes Leadership

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast version of Five Must-Know Things: Leqembi bodes well for Biogen; AbbVie predicts US Humira erosion; Sanofi’s R&D chief moves on; Roche’s ophthalmology plans; and Scrip Asks what 2023 holds for AI in pharma.

Commercial Executive Changes

J&J-Bound Reed Reaches End Of The Road As Sanofi R&D Chief

The French drugmaker has begun an external and internal search to succeed John Reed who is heading for Johnson & Johnson after an up-and-down five years as Sanofi’s R&D chief.

Executive Changes Business Strategies

Executives On The Move: Medexus Pharmaceuticals, Alliance Pharma and More

Recent executive moves in the industry include C-suite changes Alliance Pharma and Race Oncology. Meanwhile, new directors were appointed at Medexus Pharmaceuticals and Scancell Holdings.

Executive Changes Leadership

Executives On The Move: Grey Wolf Therapeutics, Fresh Tracks Therapeutics And More

Recent executive moves in the industry include C-suite changes at Fresh Tracks Therapeutics and Protara Therapeutics. Meanwhile, new directors were appointed at Grey Wolf Therapeutics and BioSenic.

Executive Changes Leadership

Executives On The Move: AVEO Pharmaceuticals, Everest Medicines and More

Recent executive changes in the industry include C-suite changes at Aveo Pharmaceuticals and Scandion Oncology. Meanwhile, new directors were appointed at Akston Biosciences and Everest Medicines. 

Executive Changes Leadership

Executives On The Move: Beijing Konruns Pharmaceutical, KemPharm and More

Recent executive changes in the industry include C-suite changes at KemPharma and Imago BioSciences. Meanwhile, new directors were appointed at Beijing Konruns Pharmaceutical and Ventyx Biosciences. 

Executive Changes Leadership

Executives On The Move: ZyVersa Therapeutics, HilleVax and More

Recent executive moves in the industry include C-suite changes at Regenxbio and HilleVax. Meanwhile, new directors were appointed at ZyVersa Therapeutics and Bioventus. 

Executive Changes Leadership
See All
UsernamePublicRestriction

Register